Clinical Trial Update: Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating inhaled nitric oxide as adjunctive therapy for cerebral malaria in children has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Malaria

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Epicentre | Conditions: Malaria, Cerebral | Phase 2 | Status: COMPLETED